Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer

Clinical trial NCT01511874 · COMPLETED

Trial details

NCT number: NCT01511874
Sponsor: HanAll BioPharma Co., Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2011-01-01
Primary completion: 2013-05-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.